Identification and comparative analysis of Pax5 C-terminal isoforms expressed in human cord blood-derived B cell progenitors

Immunology Letters

Volumn 111, Issue 1, 2007, Pages 21-25

  Sekine, Rieko ^a   Kitamura, Toshio ^a   Tsuji, Takashi ^b   Tojo, Arinobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Alternative splicing; CD19; CD34; Cord blood; Isoform; Pax5

Indexed keywords

CD19 ANTIGEN; LUCIFERASE; MESSENGER RNA; TRANSCRIPTION FACTOR PAX5;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; COCULTURE; CONTROLLED STUDY; EXON; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; UMBILICAL CORD BLOOD;

ALTERNATIVE SPLICING; ANTIGENS, CD34; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; CLONING, MOLECULAR; FEMALE; FETAL BLOOD; HUMANS; MOLECULAR SEQUENCE DATA; PREGNANCY; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34347358461     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.04.004     Document Type: Article

References (21)

1. Schebesta M., Heavey B., and Busslinger M. Transcriptional control of B-cell development. Curr Opin Immunol 14 (2002) 216-223
2. Nutt S.L., Heavey B., Rolink A.G., and Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401 (1999) 556-562
3. Urbanek P., Wang Z.Q., Fetka I., Wagner E.F., and Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79 (1994) 901-912
4. Mikkola I., Heavey B., Horcher M., and Busslinger M. Reversion of B cell commitment upon loss of Pax5 expression. Science 297 (2002) 110-113
5. Chiang M.Y., and Monroe M. BSAP/Pax5A expression blocks survival and expansion of early myeloid cells implicating its involvement in maintaining commitment to the B-lymphocyte lineage. Blood 94 (1999) 3621-3632
6. Chiang M.Y., and Monroe J.G. Role for transcription Pax5A factor in maintaining commitment to the B cell lineage by selective inhibition of granulocyte-macrophage colony-stimulating factor receptor expression. J Immunol 166 (2001) 6091-6098
7. Souabni A., Cobaleda C., Schebesta M., and Busslinger M. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17 (2002) 781-793
8. Zwollo P., Arrieta H., Ede K., Molinder K., Desiderio S., and Pollock R. The Pax-5 gene is alternatively spliced during B-cell development. J Biol Chem 272 (1997) 10160-10168
9. Busslinger M., Klix N., Pfeffer P., Graninger P.G., and Kozmik Z. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc Natl Acad Sci USA 93 (1996) 6129-6134
10. Borson N.D., Lacy M.Q., and Wettstein P.J. Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma. Blood 100 (2002) 4629-4639
11. Robichaud G.A., Nardini M., Laflamme M., Cuperlovic-Culf M., and Ouellette R.J. Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells. J Biol Chem 279 (2004) 49956-49963
12. Dorfler P., and Busslinger M. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8. EMBO J 15 (1996) 1971-1982
13. Nishihara M., Wada Y., Ogami K., Ebihara Y., Ishii T., Tsuji K., et al. A combination of stem cell factor and granulocyte colony-stimulating factor enhances the growth of human progenitor B cells supported by murine stromal cell line MS-5. Eur J Immunol 28 (1998) 855-864
14. + progenitors. Leukemia 12 (1998) 764-771
15. Nakano T., Kodama H., and Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265 (1994) 1098-1101
16. (low/-) cells generated in a xenogenic co-culture system are capable of both long-term hematopoiesis and multiple differentiation. Leukemia 13 (1999) 1409-1419
17. Yang A.X., Mejido J., Luo Y., Zeng X., Schwartz C., Wu T., et al. Development of a focused microarray to assess human embryonic stem cell differentiation. Stem Cells Dev 14 (2005) 270-284
18. Kitamura T., Koshino Y., Shibata F., Oki T., Nakajima H., Nosaka T., et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 31 (2003) 1007-1014
19. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431 (2004) 931-945
20. Kozmik Z., Kurzbauer R., Dorfler P., and Busslinger M. Alternative splicing of Pax-8 gene transcripts is developmentally regulated and generates isoforms with different transactivation properties. Mol Cell Biol 13 (1993) 6024-6035
21. Tavassoli K., Ruger W., and Horst J. Alternative splicing in PAX2 generates a new reading frame and extended conserved coding region at the carboxy terminus. Hum Genet 101 (1997) 371-375